Module contents

Module home
Module introduction
Pre-module tests
Module information
About the authors

 

Section 1: The basics

(1.1) Section 1: The basics

(1.2) Neurosis

(1.3) Related syndromes

(1.4) Anxiety disorders: prevalence

(1.5) Section 1: Recap I

(1.6) Outcome

(1.7) Factors for a good outcome

(1.8) Chronic outcome

(1.9) Section 1: Recap II

(1.10) Management of individual symptoms

(1.11) Precautions in diagnosis

(1.12 Timeframes

(1.13) Section 1: Recap III

(1.14) Suggested answers

(1.15) Section 1: Summary

 

Section 2: Pharmacotherapy for generalised anxiety disorder

(2.1) Section 2: Pharmacotherapy for generalised anxiety disorder

(2.2) Antidepressant drug treatment for GAD

(2.3) Adverse effects of imipramine

(2.4) Adverse effects of SSRIs

(2.5) Adverse effects of venlafaxine

(2.6) Buspirone

(2.7) Adverse effects of buspirone

(2.8) Antipsychotic drug treatment

(2.9) Beta-blockers

(2.10) Section 2: Recap

(2.11) Section 2: Summary

 

Section 3: Panic disorder

(3.1) Section 3: Panic disorder

(3.2) Antidepressant drug treatment of panic disorder

(3.3) Section 3: Recap

(3.4) Section 3: Recap (cont.)

(3.5) Section 3: Summary

 

Section 4: Generalised social phobia

(4.1) Section 4: Generalised social phobia

(4.2) What is social phobia?

(4.3) Some facts about social phobia

(4.4) Treatment of social phobia

(4.5) Section 4: Recap

(4.6) Section 4: Summary

 

Section 5: Further considerations

(5.1) Section 5: Further considerations

(5.2) Treatment resistance

(5.3) Depression and substance abuse

(5.4) Treatment resistance: options

(5.5) Benzodiazepines

(5.6) Pharmacotherapy to reduce risk

(5.7) Section 5: Recap

(5.8) Section 5: Summary

 

Module summary

Module test

Send feedback

 

Useful resources

Take-home notes

References

© 2021 Royal College of Psychiatrists